Disparities in identification of comorbid diagnoses in children with ADHD

Clinical Pediatrics

Volumn 54, Issue 4, 2015, Pages 376-381

  Gipson, Tanjala T ^a,b   Lance, Eboni I ^a,b   Albury, Rebecca A ^a   Gentner, Maura B ^a   Leppert, Mary L ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

attention deficit hyperactive disorder; comorbidity; polypharmacy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CAUCASIAN; CHILD; COMORBIDITY; DEMOGRAPHY; EDUCATION PROGRAM; FEMALE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HUMAN; INTELLECTUAL IMPAIRMENT; INTERVENTION STUDY; LANGUAGE DISABILITY; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION THERAPY MANAGEMENT; PATIENT IDENTIFICATION; PSYCHOSOCIAL DISORDER; RETROSPECTIVE STUDY; SCHOOL CHILD; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DEVELOPMENTAL DISABILITIES; HEALTH CARE DELIVERY; MENTAL DISORDERS; PRESCHOOL CHILD; REIMBURSEMENT; STATISTICS AND NUMERICAL DATA;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DEVELOPMENTAL DISABILITIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MENTAL DISORDERS; RETROSPECTIVE STUDIES;

EID: 84925624782     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922814553434     Document Type: Article

References (29)

1. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyper-activity disorder. J Am Acad Child Adolesc Psychiatry. 2007 ; 46: 894-921
2. ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attentiondeficit/hyperactivity disorder in children and adolescents. Paediatrics. 2011 ; 128: 1007-1022
3. Efron D, Sciberras E. The diagnostic outcomes of children with suspected attention deficit hyperactivity disorder following multidisciplinary assessment. J Paediatr Child Health. 2010 ; 46: 392-397
4. Tirosh E, Cohen A. Language deficit with attention-deficit disorder: a prevalent comorbidity. J Child Neurol. 1998 ; 13: 493-497
5. Kain W, Landerl K, Kaufmann L. Comorbidity in ADHD. Monatsschr Kinderheilkd. 2008 ; 156: 757
6. Huh Y, Choi I, Song M, Kim S, Hong SD, Joung Y. A comparison of comorbidity and psychological outcomes in children and adolescents with attention-deficit/hyperactivity disorder. Psychiatry Investig. 2011 ; 8: 95-101
7. Posner K, Melvin GA, Murray DW, et al. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: The preschoolers with attention-Deficit/Hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmacol. 2007 ; 17: 547-562
8. Wilens TE, Biederman J, Brown S, et al. Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry. 2002 ; 41: 262-268
9. August GJ, Braswell L, Thuras P. Diagnostic stability of ADHD in a community sample of school-aged children screened for disruptive behaviour. J Abnorm Child Psychol. 1998 ; 26: 345-356
10. Hechtman L. Assessment and diagnosis of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000 ; 9: 481-498
11. Hurtig T, Ebeling H, Taanila A, et al. ADHD and comorbid disorders in relation to family environment and symptom severity. Eur Child Adolesc Psychiatry. 2007 ; 16: 362-369
12. Hoffman D, Schiller M, Greenblatt J, Iosifescu D. Polypharmacy or medication washout: an old tool revisited. Neuropsychiatr Dis Treat. 2011 ; 7: 639
13. Hoagwood K, Jensen PS, Feil M, Vitiello B, Bhatara VS. Medication management of stimulants in paediatric practice settings: a national perspective. J Dev Behav Pediatr. 2000 ; 21: 322-331
14. Kingsbury SJ, Yi D, Simpson GM. Psychopharmacology: rational and irrational polypharmacy. Psychiatr Serv. 2001 ; 52: 1033-1036
15. Wilens TE, Spencer T, Biederman J, Wozniak J, Connor D. Combined pharmacotherapy: an emerging trend in paediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 1995 ; 34: 110-112
16. Woolston JL. Combined pharmacotherapy: pitfalls of treatment. J Am Acad Child Adolesc Psychiatry. 1999 ; 38: 1455-1457
17. Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 1999 ; 153: 1257-1263
18. Lipkin PH, Cozen MA, Thompson RE, Mostofsky SH. Stimulant dosage and age, race, and insurance type in a sample of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005 ; 15: 240-248
19. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: multimodal treatment study of children with ADHD. Arch Gen Psychiatry. 1999 ; 56: 1073-1086
20. Kube DA, Petersen MC, Palmer FB. Attention deficit hyperactivity disorder: comorbidity and medication use. Clin Pediatr (Phila). 2002 ; 41: 461-469
21. Hodgkins P, Sasane R, Christensen L, Harley C, Liu F. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr Med Res Opin. 2011 ; 27: 53-62
22. Waxmonsky J. Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr. 2003 ; 15: 476-482
23. Newcorn JH, Miller SR, Ivanova I, et al. Adolescent outcome of ADHD: impact of childhood conduct and anxiety disorders. CNS Spectr. 2004 ; 9: 668-678
24. Bussing R, Zima BT, Belin TR. Differential access to care for children with ADHD in special education programs. Psychiatr Serv. 1998 ; 49: 1226-1229
25. Hervey-Jumper H, Douyon K, Franco KN. Deficits in diagnosis, treatment and continuity of care in African-American children and adolescents with ADHD. J Natl Med Assoc. 2006 ; 98: 233-238
26. Merikangas KR, He JP, Burstein M, et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the national comorbidity survey-adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011 ; 50: 32-45
27. Scahill L, Schwab-Stone M, Merikangas KR, Leckman JF, Zhang H, Kasl S. Psychosocial and clinical correlates of ADHD in a community sample of school-age children. J Am Acad Child Adolesc Psychiatry. 1999 ; 38: 976-984
28. Olson BG, Rosenbaum PF, Dosa NP, Roizen NJ. Improving guideline adherence for the diagnosis of ADHD in an ambulatory paediatric setting. Ambul Pediatr. 2005 ; 5: 138-142
29. Accardo J, Shapiro BK. Neurodevelopmental disabilities: beyond the diagnosis. Semin Pediatr Neurol. 2005 ; 12: 242-249